TABLE 2.
Description of prospective cohort studies of chlamydia
| Year* | Location | Author (reference) | Study site | Study subjects | Eligibility criteria | Primary method of detection |
|---|---|---|---|---|---|---|
| 1991 | Sweden | Rahm et al (104) | One adolescent clinic | 301 females | Sexually active adolescent attenders | Culture |
| 1994 | Netherlands | Prins et al (98) | STD clinic | 234 females 155 males | Consecutive patients, heterosexual, reported ≥ 5 partners in the past six months, ≥ 18 years | Culture |
| 1996 | United States | Mosure et al (69) | 160 family planning clinics | 26,921 females | Sexually active patients having a pelvic examination who were tested for chlamydia on two or more occasions between 1988 and 1992, 15 to 19 years | DFA |
| United States | Oh et al (99) | Adolescent clinics | 216 females | Sexually active patients having pelvic examinations who had at least two visits with indications for repeat screening during the study period | Culture | |
| 1998 | United States | Burstein (34) | Three middle school clinics | 188 females | Consecutive patients | LCR |
| United States | Burstein et al (82) | Family planning, STD and school-based clinics | 3202 females | Consecutive patients, 12 to 19 years | PCR |
Year of publication;
DFA Direct fluorescent antibody; LCR Ligase chain reaction; PCR Polymerase chain reaction; STD Sexually transmitted disease